Vanda Pharmaceuticals Inc. — Director's Dealing 2009

Oct 16, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2009-10-13

Reporting Person: TANG KEVIN C (10% Owner)
Reporting Person: TANG CAPITAL MANAGEMENT LLC (10% Owner)
Reporting Person: TANG CAPITAL PARTNERS LP (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-10-13	Common Stock	S	542072	$12.7637	Disposed	3123780	Indirect
2009-10-15	Common Stock	S	57928	$11.804	Disposed	3065852	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-10-13	Call Options (obligations to sell)	$15.00	S	3000	Disposed	2010-01-16	Common Stock (300000)	Indirect
2009-10-13	Call Options (obligations to sell)	$12.50	S	3000	Disposed	2010-01-16	Common Stock (300000)	Indirect

Footnotes

F1: The securities are held by Tang Capital Partners, LP. Kevin C. Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of Tang Capital Partners, LP. Mr. Tang disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.